Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. - Wikidata - awgldk - TriplyDB

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.

http://www.wikidata.org/entity/Q48915503

about

Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies Oligodendroglioma: pathology, molecular mechanisms and markers Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype Telomere maintenance and the etiology of adult glioma TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial.Recent advances in subtyping tumors of the central nervous system using molecular data.TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas The role of telomerase protein TERT in Alzheimer's disease and in tau-related pathology in vitro.A primary melanoma and its asynchronous metastasis highlight the role of BRAF, CDKN2A, and TERT Recurrent 12q13-15 chromosomal aberrations, high frequency of isocitrate dehydrogenase 1 mutations, and absence of high mobility group AT-hook 2 expression in periosteal chondromas.TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.A somatic reference standard for cancer genome sequencing.Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis Combination genetic signature stratifies lower-grade gliomas better than histological grade.TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas.TERT promoter mutations are a rare event in gastrointestinal stromal tumors Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.Biomarker-based prognostic stratification of young adult glioblastoma Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma.TERT Promoter Mutations and Risk of Recurrence in Meningioma.Copy Number Profiling of Brazilian Astrocytomas Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge.Telomerase promoter mutations in cancer: an emerging molecular biomarker?The evolving molecular genetics of low-grade glioma.Anaplastic glioma: current treatment and management.Glioblastoma: pathology, molecular mechanisms and markers.Diagnostic, prognostic and predictive relevance of molecular markers in gliomas.Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers.Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.Molecular profiling of gliomas: potential therapeutic implications.Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model.Evolving Molecular Genetics of Glioblastoma.Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens.

P2860

Q26738705-1831DBAA-399D-422B-A1E1-0B986E730C73 Q26739925-B9C9D3E6-2AB9-48F2-BF6A-4FEC23105F60 Q26744271-688BBDE1-B8BF-42D7-AAC3-725C555DE3B3 Q27002448-E7869841-23C7-4B93-B7BA-B482A1110BC4 Q27852966-AA9D3A35-D5D3-480C-9B10-C213D8C864E8 Q28071562-EA2E165F-50BB-42FA-A593-16EADEFB4205 Q28084275-DD97D36B-4D7E-41CF-93AE-37D29FFDFEDA Q28397245-6C3DB1CF-2E66-435D-96B5-1255B4BAE6A9 Q30836702-F4E7CC86-A280-4AF4-91CA-FD356606B052 Q31145092-DD4A2130-EA67-4A76-A006-2FFB70F67876 Q33414576-F055C810-E724-4172-96BB-D0639CC5F6DB Q33429964-0A0D1D24-D0B9-4E7A-B222-FB1DA31903DC Q33688915-89EBCFFA-10AA-4279-ACFD-ACA24852F122 Q35020283-497D6F9E-5EE2-477E-A827-5BBEE817044A Q35751775-8F7D2F10-21EA-4AB9-9F9A-BA4C0F6A2497 Q35804043-10A0331D-25CF-40DF-A3CB-B8CA6B935B69 Q35833084-D3C767CF-94A9-4523-868F-8B30499AE29E Q35994200-F86E70F8-9966-49DA-AC22-6BDF95B29457 Q36107360-6AF68917-8F06-4271-9CA9-36E8506D1F52 Q36356194-BADD1DBF-4E32-43FC-97D3-4B7DD64FD1ED Q36413047-50BFF0E0-CE8B-4A78-A9FC-FE7B750E1342 Q36415418-271C39A8-F6EB-45F6-B2EA-035583CC08CE Q36618268-0A5FFE1F-FB24-4C08-A291-48EF7D0A00F0 Q36782664-8338A475-9E5A-47C9-9F50-984204C7C6FB Q36786297-548D345D-3839-454E-A377-08C41179D820 Q36849156-64840CA3-3215-4DDE-9563-D834AD7DC296 Q37079525-A820F6CC-D9E0-47C4-BE97-E6FBDB601C5D Q37662100-40058594-F5F7-4531-83AB-6227A36E791D Q37729676-592EFB13-204F-4E76-9F8E-53AF388A2B84 Q38232447-CAB50C74-D4FA-4544-AA96-4C300871F55B Q38349169-4A58CCF2-213C-4A93-A697-1A7AAFED3670 Q38456018-39EB1016-EDA2-4579-B8B2-8F39DD616056 Q38460865-0CC45908-CA13-421F-A738-0B98C6554556 Q38461565-3D469AF9-29F0-4415-9A10-A67EE0018C24 Q38480437-30BB5BAB-7101-493C-8852-C7147AFB894F Q38526029-EEB3ADD4-8F9C-4A04-94C9-B6C49DFFD2E0 Q38539422-0136049A-4A72-42CB-9FB1-3CACC95E8C51 Q38668396-09EC1C95-9459-4104-991B-9E64D7774203 Q38734366-AE225BAF-4AA1-4576-A189-026625D71566 Q38741186-799EBCF1-00EE-4B84-B725-B7F9B9F73B22

P2860

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.

http://www.wikidata.org/entity/Q48915503

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Distribution of TERT promoter ...... tumors of the nervous system.

@en

Distribution of TERT promoter ...... tumors of the nervous system.

@nl

type

label

Distribution of TERT promoter ...... tumors of the nervous system.

@en

Distribution of TERT promoter ...... tumors of the nervous system.

@nl

prefLabel

Distribution of TERT promoter ...... tumors of the nervous system.

@en

Distribution of TERT promoter ...... tumors of the nervous system.

@nl

P1433

Q48915503-E265E7A6-387C-4D68-9176-253026718132

P1476

Q48915503-B3850D81-BB5E-4A9F-92D5-4201FB13F445

P2093

Q48915503-001C66EF-BD70-4772-A43F-3C64D87518F4

Q48915503-02394DB8-8498-4953-B0AE-2E639B34DC40

Q48915503-471CE6B8-1BC1-4C39-94B6-99F4B28C1E88

Q48915503-474BDB25-B040-4BD4-B4EA-1C9474FDDD0F

Q48915503-539BC6EF-D2F8-4100-BD59-29F852F50E28

Q48915503-7F6B82AD-1EF9-4F8E-903C-885D86070722

Q48915503-8FADBD23-CF37-40CA-8E47-9BBBF17331A2

Q48915503-951CE6BB-809E-4420-A6EB-0E00A259E541

Q48915503-983C80A6-06B9-42EB-9598-885D8C30180D

Q48915503-ABA9B83E-770E-466E-800C-99527F33660B

P2860

Q48915503-07B7518F-FF15-4FBA-B391-F601205FC62D

Q48915503-0AD7405B-6825-4E25-9139-0975470EBB1B

Q48915503-17BFFFBD-A1B6-46D6-9A74-FB4BEDB56FF9

Q48915503-27F41890-D071-4DDC-B326-FB5B61C4CD07

Q48915503-2AD6724D-826D-4E13-B94C-C9F171FF58C0

Q48915503-2CF3CF8E-50E1-4749-BAAC-3F0FB2E0D1CE

Q48915503-454D4222-C162-41B5-A244-B0704D1C731F

Q48915503-4D3F14D6-A78D-4213-8BBC-7AFDD0F64853

Q48915503-5BAC5BFD-B0F7-4B14-8AE3-DF5A827D385B

Q48915503-6473F711-6247-4AAE-8D52-9C561AD452C1

P2888

Q48915503-E6056D29-E955-46AE-8057-E81A6AA81830

P304

Q48915503-731D00E6-0F21-40C9-9847-B3ED37ED0EF4

P31

Q48915503-790B8CF7-2E0F-40F4-A22B-1F6EC1A9C761

P356

Q48915503-2FD0DCC1-130E-470B-86CC-7AE8F8E1ED37

P433

Q48915503-6B0D5180-0D5D-4F46-A67F-4008D03AE245

P478

Q48915503-AC735E7D-C25E-41C6-8B85-5D80C7DF238D

P50

Q48915503-32146F8C-7712-4B23-85DC-9B56BFE8887A

Q48915503-44E6E192-C05F-4958-A75F-81806982240C

Q48915503-45735DD2-5671-4AD8-911F-6F247CAFE147

Q48915503-76E2B892-0E23-4966-AC25-A08E56B10F60

Q48915503-83DA347F-A21C-4042-9665-DA8120BA8914

Q48915503-A3749643-E980-4395-9115-F76D57530EA7

Q48915503-C2AF58CA-37E4-4FB8-A549-BB444EB1667D

Q48915503-CFB1565A-76CC-4AEE-B113-AB865B6A013A

Q48915503-D77FC55E-85A9-47F5-B328-B7EFF2E106D0

Q48915503-E34C197D-FBD2-4DF6-B45E-44DA8FD7BFF0

P577

Q48915503-62541797-EC0A-4CE9-8C07-9B73AE941EA9

P698

Q48915503-97B6A0D1-C772-460B-ABB1-C17D03D77CE8

P356

S00401-013-1195-5

P1433

Acta Neuropathologica

P1476

Distribution of TERT promoter ...... tumors of the nervous system.

@en

P2093

Andreas Unterberg

http://www.w3.org/2001/XMLSchema#string

Andrey Korshunov

http://www.w3.org/2001/XMLSchema#string

Benedikt Wiestler

http://www.w3.org/2001/XMLSchema#string

Benjamin Brokinkel

http://www.w3.org/2001/XMLSchema#string

Christian Hartmann

http://www.w3.org/2001/XMLSchema#string

Christian Koelsche

http://www.w3.org/2001/XMLSchema#string

Christian Mawrin

http://www.w3.org/2001/XMLSchema#string

David Reuss

http://www.w3.org/2001/XMLSchema#string

David T W Jones

http://www.w3.org/2001/XMLSchema#string

Jochen Meyer

http://www.w3.org/2001/XMLSchema#string

P2860

Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.

TERT promoter mutations in primary and secondary glioblastomas.

Mutations of the BRAF gene in human cancer

Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway

Highly recurrent TERT promoter mutations in human melanoma

A survey of telomerase activity in human cancer

TERT promoter mutations in familial and sporadic melanoma

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

P2888

s00401-013-1195-5

P304

907-915

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-013-1195-5

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P50

Michael Platten

Stefan M Pfister

Andreas von Deimling

Christel Herold-Mende

Jens Schittenhelm

P577

2013-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24154961

http://www.w3.org/2001/XMLSchema#string